Literature DB >> 7513291

Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.

M Dean1, G Santis.   

Abstract

Cystic fibrosis is a common, fatal disorder caused by abnormalities in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR encodes a chloride channel that regulates secretion in many exocrine tissues. The presentation of cystic fibrosis is highly variable as measured by the age of onset of disease, the presence of pancreatic insufficiency, or the progression of lung disease. Over 400 mutations in the CFTR gene have been described in cystic fibrosis patients and considerable effort has focused on the correlation between specific mutations and genotypes and clinical characteristics. Individual tissues display variation in their sensitivity to CFTR mutations. The vas deferens is functionally disrupted in nearly all males, whereas mild and severe pancreatic involvement is determined by the patient's genotype. The severity of pulmonary disease is poorly correlated with genotype, suggesting that there are other important genetic and/or environmental factors that contribute to lung infections and the subsequent disruption of lung function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513291     DOI: 10.1007/bf00201659

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

1.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

2.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.

Authors:  T Miyazaki; M Uno; M Uehira; H Kikutani; T Kishimoto; M Kimoto; H Nishimoto; J Miyazaki; K Yamamura
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

3.  Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.

Authors:  H K Johansen; M Nir; N Høiby; C Koch; M Schwartz
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

6.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

7.  Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

Authors:  T Shoshani; A Augarten; E Gazit; N Bashan; Y Yahav; Y Rivlin; A Tal; H Seret; L Yaar; E Kerem
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

8.  Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis.

Authors:  S Lanng; M Schwartz; B Thorsteinsson; C Koch
Journal:  Clin Genet       Date:  1991-11       Impact factor: 4.438

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  P Kubesch; T Dörk; U Wulbrand; N Kälin; T Neumann; B Wulf; H Geerlings; H Weissbrodt; H von der Hardt; B Tümmler
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

View more
  15 in total

Review 1.  Genetically determined male infertility and assisted reproduction techniques.

Authors:  T Hargreave
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

Review 2.  Purinergic regulation of epithelial transport.

Authors:  R Elaine Bucheimer; Joel Linden
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

3.  Association screening of common and rare genetic variants by penalized regression.

Authors:  Hua Zhou; Mary E Sehl; Janet S Sinsheimer; Kenneth Lange
Journal:  Bioinformatics       Date:  2010-08-06       Impact factor: 6.937

4.  Marked improvement in cystic fibrosis lung disease and nutrition following change in home environment.

Authors:  Atul Gupta; Donald Urquhart; Mark Rosenthal
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

5.  Discordant phenotype in siblings with X-linked agammaglobulinemia.

Authors:  M J Bykowsky; R N Haire; Y Ohta; H Tang; S S Sung; E S Veksler; J M Greene; S M Fu; G W Litman; K E Sullivan
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Detection of susceptibility genes as modifiers due to subgroup differences in complex disease.

Authors:  Sarah E Bergen; Brion S Maher; Ayman H Fanous; Kenneth S Kendler
Journal:  Eur J Hum Genet       Date:  2010-03-31       Impact factor: 4.246

Review 7.  Regulation of epithelial ion channels by the cystic fibrosis transmembrane conductance regulator.

Authors:  R Greger; M Mall; M Bleich; D Ecke; R Warth; N Riedemann; K Kunzelmann
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 8.  The genetic contribution to the phenotype.

Authors:  U Wolf
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

9.  Clinical features of cystic fibrosis patients with rare genotypes.

Authors:  G Castaldo; E Rippa; V Raia; D Salvatore; C Massa; G de Ritis; F Salvatore
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

10.  A groupwise association test for rare mutations using a weighted sum statistic.

Authors:  Bo Eskerod Madsen; Sharon R Browning
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.